Bank of America’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.94M | Buy |
295,477
+139,865
| +90% | +$1.87M | ﹤0.01% | 3509 |
|
|
2025
Q1 | $1.59M | Sell |
155,612
-5,855
| -4% | -$59.7K | ﹤0.01% | 4076 |
|
|
2024
Q4 | $2.56M | Sell |
161,467
-9,604
| -6% | -$152K | ﹤0.01% | 3573 |
|
|
2024
Q3 | $9.93M | Sell |
171,071
-7,923
| -4% | -$460K | ﹤0.01% | 2628 |
|
|
2024
Q2 | $8.18M | Buy |
178,994
+6,517
| +4% | +$298K | ﹤0.01% | 2718 |
|
|
2024
Q1 | $11.4M | Sell |
172,477
-20,972
| -11% | -$1.39M | ﹤0.01% | 2452 |
|
|
2023
Q4 | $7.69M | Buy |
193,449
+138,799
| +254% | +$5.52M | ﹤0.01% | 2648 |
|
|
2023
Q3 | $1.74M | Sell |
54,650
-1,563
| -3% | -$49.8K | ﹤0.01% | 3654 |
|
|
2023
Q2 | $2.26M | Sell |
56,213
-19,456
| -26% | -$782K | ﹤0.01% | 3464 |
|
|
2023
Q1 | $3.23M | Buy |
75,669
+9,728
| +15% | +$415K | ﹤0.01% | 3362 |
|
|
2022
Q4 | $3.17M | Buy |
65,941
+12,831
| +24% | +$616K | ﹤0.01% | 3290 |
|
|
2022
Q3 | $2M | Buy |
53,110
+14,341
| +37% | +$540K | ﹤0.01% | 3652 |
|
|
2022
Q2 | $1.07M | Buy |
38,769
+4,480
| +13% | +$124K | ﹤0.01% | 4198 |
|
|
2022
Q1 | $1.86M | Buy |
34,289
+2,926
| +9% | +$159K | ﹤0.01% | 4051 |
|
|
2021
Q4 | $1.84M | Buy |
31,363
+1,216
| +4% | +$71.1K | ﹤0.01% | 3986 |
|
|
2021
Q3 | $1.19M | Buy |
30,147
+22,154
| +277% | +$877K | ﹤0.01% | 4203 |
|
|
2021
Q2 | $339K | Sell |
7,993
-6,494
| -45% | -$275K | ﹤0.01% | 4979 |
|
|
2021
Q1 | $892K | Buy |
14,487
+12,388
| +590% | +$763K | ﹤0.01% | 4348 |
|
|
2020
Q4 | $148K | Buy |
2,099
+1,121
| +115% | +$79K | ﹤0.01% | 5057 |
|
|
2020
Q3 | $38K | Sell |
978
-8,385
| -90% | -$326K | ﹤0.01% | 5454 |
|
|
2020
Q2 | $351K | Buy |
+9,363
| New | +$351K | ﹤0.01% | 4355 |
|